In silico methods and tools for drug discovery.

Area of Science:

• Pharmacology
• Computational Chemistry
• Drug Discovery

Background:

• Traditional drug discovery is time-consuming (over 12 years) and costly (approx. $1.8 billion USD).
• In silico approaches offer a promising alternative to expedite drug development.
• Computational methods have a proven track record in successfully developing new drug compounds.

Purpose of the Study:

• To introduce computational drug discovery strategies.
• To outline current tools and knowledge bases for computational modeling.
• To present successful examples of drug discovery using computational methods.

Main Methods:

• Review of in silico drug discovery strategies.
• Identification of up-to-date computational tools.
• Compilation of available knowledge bases for model development.
• Analysis of case studies in anti-bacterial, anti-viral, and anti-cancer drug discovery.

Main Results:

• In silico approaches significantly reduce time, labor, and costs in drug discovery.
• A range of computational tools and databases are available for researchers.
• Successful applications of computational methods have been demonstrated in developing anti-infective and anti-cancer agents.

Conclusions:

• Computational drug discovery is a viable and efficient strategy for modern pharmaceutical research.
• The availability of advanced tools and knowledge bases empowers researchers to develop novel therapeutics.
• In silico methods are crucial for accelerating the development of drugs against various diseases, including bacterial, viral, and cancer indications.